Cargando…

Dopamine, Immunity, and Disease

The neurotransmitter dopamine is a key factor in central nervous system (CNS) function, regulating many processes including reward, movement, and cognition. Dopamine also regulates critical functions in peripheral organs, such as blood pressure, renal activity, and intestinal motility. Beyond these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Channer, Breana, Matt, Stephanie M., Nickoloff-Bybel, Emily A., Pappa, Vasiliki, Agarwal, Yash, Wickman, Jason, Gaskill, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832385/ https://www.ncbi.nlm.nih.gov/pubmed/36757901 http://dx.doi.org/10.1124/pharmrev.122.000618

Ejemplares similares

Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV
por: Matt, Stephanie M., et al.
Publicado: (2021)

Co-receptor signaling in the pathogenesis of neuroHIV
por: Nickoloff-Bybel, E. A., et al.
Publicado: (2021)

Zebrafish Trak proteins 1a and 2 localize to the mitochondria
por: Oonk, Kelsey A, et al.
Publicado: (2020)

Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
por: Nolan, R.A., et al.
Publicado: (2019)

Dopamine: an immune transmitter
por: Thomas Broome, Sarah, et al.
Publicado: (2020)

Case Presentations in Heart Disease
por: Channer, Kevin S.
Publicado: (1992)

Physical Signs in Cardiovascular Disease
por: Channer, K. S.
Publicado: (1989)

Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages
por: Gaskill, Peter J., et al.
Publicado: (2014)

Dopamine Increases CD14(+)CD16(+) Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis
por: Coley, Jacqueline S., et al.
Publicado: (2015)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

Vitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?
por: Cervantes, Breana, et al.
Publicado: (2017)

Potential Roles of Peripheral Dopamine in Tumor Immunity
por: Zhang, Xiang, et al.
Publicado: (2017)

Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy
por: Nickoloff, Jac A.
Publicado: (2022)

Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors
por: Myslivecek, Jaromir
Publicado: (2022)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Role of Dopamine in the Heart in Health and Disease
por: Neumann, Joachim, et al.
Publicado: (2023)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Dopamine, behavior, and addiction
por: Wise, Roy A., et al.
Publicado: (2021)

From Enzymatic Dopamine Biosensors to OECT Biosensors of Dopamine
por: Ravariu, Cristian
Publicado: (2023)

Severity of neonatal influenza infection is driven by type I interferon and oxidative stress
por: Kumova, Ogan K., et al.
Publicado: (2022)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Dopamine Agonists and Pathologic Behaviors
por: Kelley, Brendan J., et al.
Publicado: (2012)

Clustered DNA Double-Strand Breaks: Biological Effects and Relevance to Cancer Radiotherapy
por: Nickoloff, Jac A., et al.
Publicado: (2020)

Safety out of control: dopamine and defence
por: Lloyd, Kevin, et al.
Publicado: (2016)

Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists
por: Connors, Jennifer, et al.
Publicado: (2022)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
por: Chen, Allen PF, et al.
Publicado: (2021)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
por: Perez, Stephanie M, et al.
Publicado: (2014)

Alcohol and Dopamine
por: Di Chiara, Gaetano
Publicado: (1997)

Complexity of dopamine metabolism
por: Meiser, Johannes, et al.
Publicado: (2013)

Dopamine, Prediction Error and Beyond
por: Diederen, Kelly M. J., et al.
Publicado: (2020)

Differential Impact of Inhibitory G-Protein Signaling Pathways in Ventral Tegmental Area Dopamine Neurons on Behavioral Sensitivity to Cocaine and Morphine
por: DeBaker, Margot C., et al.
Publicado: (2021)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Lipid Rafts and Dopamine Receptor Signaling
por: Martinez, Victor J., et al.
Publicado: (2020)

Human Aldehyde Dehydrogenases: A Superfamily of Similar Yet Different Proteins Highly Related to Cancer
por: Xanthis, Vasileios, et al.
Publicado: (2023)

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy
por: Nickoloff, Jac A., et al.
Publicado: (2021)

Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
por: Björklund, Anders, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9s0g8703n63et6vfnqmcufe6qi